Logo image of CLRN.DE

CLARIANT AG-REG (CLRN.DE) Stock Fundamental Analysis

Europe - FRA:CLRN - CH0012142631 - Common Stock

7.51 EUR
+0.12 (+1.62%)
Last: 11/12/2025, 7:00:00 PM
Fundamental Rating

5

CLRN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 67 industry peers in the Chemicals industry. While CLRN is still in line with the averages on profitability rating, there are concerns on its financial health. CLRN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CLRN had positive earnings in the past year.
In the past year CLRN had a positive cash flow from operations.
CLRN had positive earnings in each of the past 5 years.
In the past 5 years CLRN always reported a positive cash flow from operatings.
CLRN.DE Yearly Net Income VS EBIT VS OCF VS FCFCLRN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

The Return On Assets of CLRN (1.94%) is comparable to the rest of the industry.
With a Return On Equity value of 5.91%, CLRN perfoms like the industry average, outperforming 59.70% of the companies in the same industry.
CLRN's Return On Invested Capital of 8.53% is fine compared to the rest of the industry. CLRN outperforms 74.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLRN is above the industry average of 7.01%.
Industry RankSector Rank
ROA 1.94%
ROE 5.91%
ROIC 8.53%
ROA(3y)2.59%
ROA(5y)4.79%
ROE(3y)6.89%
ROE(5y)14.05%
ROIC(3y)9.12%
ROIC(5y)8.14%
CLRN.DE Yearly ROA, ROE, ROICCLRN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 2.78%, CLRN is in line with its industry, outperforming 56.72% of the companies in the same industry.
In the last couple of years the Profit Margin of CLRN has grown nicely.
The Operating Margin of CLRN (10.34%) is better than 71.64% of its industry peers.
In the last couple of years the Operating Margin of CLRN has remained more or less at the same level.
CLRN has a Gross Margin of 31.80%. This is comparable to the rest of the industry: CLRN outperforms 47.76% of its industry peers.
CLRN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.34%
PM (TTM) 2.78%
GM 31.8%
OM growth 3Y-1.74%
OM growth 5Y1.06%
PM growth 3Y-9.27%
PM growth 5Y91.64%
GM growth 3Y1.45%
GM growth 5Y-0.24%
CLRN.DE Yearly Profit, Operating, Gross MarginsCLRN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

CLRN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CLRN has about the same amount of shares outstanding.
The number of shares outstanding for CLRN has been reduced compared to 5 years ago.
CLRN has a worse debt/assets ratio than last year.
CLRN.DE Yearly Shares OutstandingCLRN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CLRN.DE Yearly Total Debt VS Total AssetsCLRN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CLRN has an Altman-Z score of 2.13. This is not the best score and indicates that CLRN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CLRN (2.13) is comparable to the rest of the industry.
CLRN has a debt to FCF ratio of 9.10. This is a negative value and a sign of low solvency as CLRN would need 9.10 years to pay back of all of its debts.
CLRN's Debt to FCF ratio of 9.10 is fine compared to the rest of the industry. CLRN outperforms 67.16% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that CLRN is somewhat dependend on debt financing.
CLRN's Debt to Equity ratio of 0.78 is on the low side compared to the rest of the industry. CLRN is outperformed by 70.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.1
Altman-Z 2.13
ROIC/WACC1.76
WACC4.85%
CLRN.DE Yearly LT Debt VS Equity VS FCFCLRN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

A Current Ratio of 1.36 indicates that CLRN should not have too much problems paying its short term obligations.
CLRN has a Current ratio of 1.36. This is in the lower half of the industry: CLRN underperforms 71.64% of its industry peers.
CLRN has a Quick Ratio of 1.36. This is a bad value and indicates that CLRN is not financially healthy enough and could expect problems in meeting its short term obligations.
CLRN has a Quick ratio of 0.90. This is in the lower half of the industry: CLRN underperforms 65.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.9
CLRN.DE Yearly Current Assets VS Current LiabilitesCLRN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.04% over the past year.
Measured over the past years, CLRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 89.79% on average per year.
Looking at the last year, CLRN shows a decrease in Revenue. The Revenue has decreased by -2.40% in the last year.
Measured over the past years, CLRN shows a decrease in Revenue. The Revenue has been decreasing by -1.15% on average per year.
EPS 1Y (TTM)34.04%
EPS 3Y-10.78%
EPS 5Y89.79%
EPS Q2Q%-83.42%
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y-1.71%
Revenue growth 5Y-1.15%
Sales Q2Q%-53.24%

3.2 Future

Based on estimates for the next years, CLRN will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.01% on average per year.
CLRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.94% yearly.
EPS Next Y-13.51%
EPS Next 2Y2.63%
EPS Next 3Y6.22%
EPS Next 5Y9.01%
Revenue Next Year-4.28%
Revenue Next 2Y-0.88%
Revenue Next 3Y0.66%
Revenue Next 5Y0.94%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLRN.DE Yearly Revenue VS EstimatesCLRN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
CLRN.DE Yearly EPS VS EstimatesCLRN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.30 indicates a rather expensive valuation of CLRN.
Compared to the rest of the industry, the Price/Earnings ratio of CLRN indicates a somewhat cheap valuation: CLRN is cheaper than 61.19% of the companies listed in the same industry.
CLRN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.34.
With a Price/Forward Earnings ratio of 7.88, the valuation of CLRN can be described as very cheap.
Based on the Price/Forward Earnings ratio, CLRN is valued cheaply inside the industry as 97.01% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CLRN to the average of the S&P500 Index (34.43), we can say CLRN is valued rather cheaply.
Industry RankSector Rank
PE 20.3
Fwd PE 7.88
CLRN.DE Price Earnings VS Forward Price EarningsCLRN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

82.09% of the companies in the same industry are more expensive than CLRN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLRN indicates a rather cheap valuation: CLRN is cheaper than 95.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.25
EV/EBITDA 5.62
CLRN.DE Per share dataCLRN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of CLRN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.23
EPS Next 2Y2.63%
EPS Next 3Y6.22%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.12%, CLRN is a good candidate for dividend investing.
CLRN's Dividend Yield is rather good when compared to the industry average which is at 3.26. CLRN pays more dividend than 89.55% of the companies in the same industry.
CLRN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.12%

5.2 History

The dividend of CLRN decreases each year by -5.09%.
Dividend Growth(5Y)-5.09%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

123.01% of the earnings are spent on dividend by CLRN. This is not a sustainable payout ratio.
DP123.01%
EPS Next 2Y2.63%
EPS Next 3Y6.22%
CLRN.DE Yearly Income VS Free CF VS DividendCLRN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CLRN.DE Dividend Payout.CLRN.DE Dividend Payout, showing the Payout Ratio.CLRN.DE Dividend Payout.PayoutRetained Earnings

CLARIANT AG-REG

FRA:CLRN (11/12/2025, 7:00:00 PM)

7.51

+0.12 (+1.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-30 2025-10-30
Earnings (Next)02-26 2026-02-26/amc
Inst Owners56.08%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap2.49B
Revenue(TTM)4.06B
Net Income(TTM)113.00M
Analysts70.48
Price Target11.9 (58.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.12%
Yearly Dividend0.45
Dividend Growth(5Y)-5.09%
DP123.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.66%
PT rev (3m)-6.35%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.44%
EPS NY rev (3m)-17.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-3.05%
Valuation
Industry RankSector Rank
PE 20.3
Fwd PE 7.88
P/S 0.57
P/FCF 10.25
P/OCF 5.46
P/B 1.21
P/tB 5.6
EV/EBITDA 5.62
EPS(TTM)0.37
EY4.93%
EPS(NY)0.95
Fwd EY12.69%
FCF(TTM)0.73
FCFY9.76%
OCF(TTM)1.37
OCFY18.3%
SpS13.23
BVpS6.22
TBVpS1.34
PEG (NY)N/A
PEG (5Y)0.23
Graham Number7.2
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 5.91%
ROCE 9.85%
ROIC 8.53%
ROICexc 9.54%
ROICexgc 15.71%
OM 10.34%
PM (TTM) 2.78%
GM 31.8%
FCFM 5.54%
ROA(3y)2.59%
ROA(5y)4.79%
ROE(3y)6.89%
ROE(5y)14.05%
ROIC(3y)9.12%
ROIC(5y)8.14%
ROICexc(3y)10.63%
ROICexc(5y)9.45%
ROICexgc(3y)15.35%
ROICexgc(5y)13.55%
ROCE(3y)10.52%
ROCE(5y)9.41%
ROICexgc growth 3Y0.58%
ROICexgc growth 5Y6.23%
ROICexc growth 3Y-3.64%
ROICexc growth 5Y2.78%
OM growth 3Y-1.74%
OM growth 5Y1.06%
PM growth 3Y-9.27%
PM growth 5Y91.64%
GM growth 3Y1.45%
GM growth 5Y-0.24%
F-Score8
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.1
Debt/EBITDA 2.23
Cap/Depr 78.49%
Cap/Sales 4.85%
Interest Coverage 5.75
Cash Conversion 62.89%
Profit Quality 199.12%
Current Ratio 1.36
Quick Ratio 0.9
Altman-Z 2.13
F-Score8
WACC4.85%
ROIC/WACC1.76
Cap/Depr(3y)83.05%
Cap/Depr(5y)99.02%
Cap/Sales(3y)4.61%
Cap/Sales(5y)5.96%
Profit Quality(3y)196.87%
Profit Quality(5y)120.08%
High Growth Momentum
Growth
EPS 1Y (TTM)34.04%
EPS 3Y-10.78%
EPS 5Y89.79%
EPS Q2Q%-83.42%
EPS Next Y-13.51%
EPS Next 2Y2.63%
EPS Next 3Y6.22%
EPS Next 5Y9.01%
Revenue 1Y (TTM)-2.4%
Revenue growth 3Y-1.71%
Revenue growth 5Y-1.15%
Sales Q2Q%-53.24%
Revenue Next Year-4.28%
Revenue Next 2Y-0.88%
Revenue Next 3Y0.66%
Revenue Next 5Y0.94%
EBIT growth 1Y7.69%
EBIT growth 3Y-3.42%
EBIT growth 5Y-0.1%
EBIT Next Year57.47%
EBIT Next 3Y22.41%
EBIT Next 5Y13.18%
FCF growth 1Y-43.61%
FCF growth 3Y311.47%
FCF growth 5Y-1.02%
OCF growth 1Y-29.31%
OCF growth 3Y4.81%
OCF growth 5Y-3.86%

CLARIANT AG-REG / CLRN.DE FAQ

What is the ChartMill fundamental rating of CLARIANT AG-REG (CLRN.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CLRN.DE.


What is the valuation status of CLARIANT AG-REG (CLRN.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to CLARIANT AG-REG (CLRN.DE). This can be considered as Fairly Valued.


How profitable is CLARIANT AG-REG (CLRN.DE) stock?

CLARIANT AG-REG (CLRN.DE) has a profitability rating of 6 / 10.


What is the valuation of CLARIANT AG-REG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CLARIANT AG-REG (CLRN.DE) is 20.3 and the Price/Book (PB) ratio is 1.21.


How sustainable is the dividend of CLARIANT AG-REG (CLRN.DE) stock?

The dividend rating of CLARIANT AG-REG (CLRN.DE) is 5 / 10 and the dividend payout ratio is 123.01%.